glp-1 drugs and lupus Show Benefits in Patients With Diabetes The anti-inflammatory and immunological properties

* These are different articles

CLINICAL APPLICATION OF GLP-1 IN LIPID METABOLISM AND ADIPOSE-RELATED DISORDERS Effects of glp-/glucose-dependent insulinotropic peptide dual agonists on lipid metabolism GLP-/glucose-dependent insulinotropic peptide (GIP) dual agonists are a new type of oral hypoglycemic drug, which can activate both GLP-1 and GIP incretin at the same time, thereby exerting a more comprehensive blood glucose control effect [125]

Im seeing real positive impact in my patients in clinic every day

2014;9 doi: 10.1371/journal.pone.0097554

The people I see in clinic, they care about getting out of a chair, playing with their grandchildren, not being admitted into a nursing home, Batsis says

Pemvidutide and survodutide are both GLP-1/glucagon dual agonists being developed for obesity and MASH, but survodutide is further ahead in clinical development with more advanced Phase 3 programs, higher-tier regulatory designations (Breakthrough Therapy vs Fast Track), and greater weight loss in Phase 2 (18.7% vs 15.6%)